Jennifer M. Beierlein

Contribution of NIH funding to new drug approvals 2010–2016

Ekaterina Galkina Cleary, Jennifer M. Beierlein, Navleen Surjit Khanuja et al. · Proceedings of the National Academy of Sciences · 2018 · 232 citations · Full text

Highly Efficient Ligands for Dihydrofolate Reductase from <i>Cryptosporidium </i><i>hominis</i> and <i>Toxoplasma </i><i>gondii</i> Inspired by Structural Analysis

Phillip M. Pelphrey, Veljko M. Popov, Tammy M. Joska et al. · Journal of Medicinal Chemistry · 2007 · 74 citations · Full text

Crystal Structure, Bioorganic Chemistry, Highly Efficient Ligands +21

NIH's Helping to End Addiction Long-termSM Initiative (NIH HEAL Initiative) Clinical Pain Management Common Data Element Program

Laura D. Wandner, Anthony F. Domenichiello, Jennifer M. Beierlein et al. · Journal of Pain · 2021 · 55 citations

Synthetic and Crystallographic Studies of a New Inhibitor Series Targeting <i>Bacillus anthracis</i> Dihydrofolate Reductase

Jennifer M. Beierlein, Kathleen M. Frey, David B. Bolstad et al. · Journal of Medicinal Chemistry · 2008 · 44 citations · Full text

As Technologies for Nucleotide Therapeutics Mature, Products Emerge

Jennifer M. Beierlein, Laura M. McNamee, Fred D. Ledley · Molecular Therapy — Nucleic Acids · 2017 · 26 citations · Full text